XML 54 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Deficit (Tables)
3 Months Ended
Apr. 30, 2013
Stockholders' Equity Note [Abstract]  
Fair Value Of Closing Stock Price Based On Assumptions
The calculation was based on the Company’s closing stock price on the date of grant and the following weighted-average inputs:

 

Expected term (years)     3.0  
Volatility     17.4 %
Dividends     0.0 %
Interest rate     0.82 %
Fair Value Of Options Granted Based On Assumptions

The weighted-average inputs for the three months ended April 30, 2013 were as follows:

 

Exercise Price   $ 0.41  
Expected Term (in years)   $ 4.59  
Volatility     26.0 %
Dividend rate     0.0 %
Interest rate     0.5 %
Stock Option Transactions Under Stock Option Plans

Stock option activity for the three months ended April 30, 2013 is summarized below:

 

          Weighted     Weighted        
          Average     Average        
          Per Share     Remaining     Aggregate  
          Exercise     Life     Intrinsic  
    Shares     Price     (Years)     Value  
Balance, January 31, 2013     5,300,000     $ 0.18       9.1     $ -  
Granted     532,000       0.37       9.7       -  
Exercised     -       -       -       -  
Expired     -       -       -       -  
Forfeited     -       -       -       -  
Balance, April 30, 2013     5,832,000     $ 0.20       9.1     $ -  
                                 
Vested and exercisable - April 30, 2013     3,398,419     $ 0.20       8.9     $ -  
Summary of Stock Based Compensation Expense Related To Restricted Stock and Option Awards

Stock-based compensation expense related to restricted stock and option awards is recognized over their respective vesting periods, and is as follows for the three months ended April 30:

 

    2013     2012  
Stock-based compensation expense:                
Cost of services   $ 147,895     $ 61,254  
General and administrative     475,331       42,880  
    $ 623,226     $ 104,134  
Total Unrecognized Compensation Costs Related To Non-Vested Stock-Based Compensation Arrangements

As of April 30, 2013, total unrecognized compensation costs related to non-vested stock-based compensation arrangements granted under our 2010 and 2013 Equity Plans, and the ACO Plan’s and the weighted-average period of years expected to recognize those costs are as follows:

 

    Unrecognized
Compensation
Cost
    Weighted 
Average
Remaining
Life
(Years)
 
             
Common stock options   $ 326,128       0.8  
                 
ACO Plan restricted stock   $ 21,525       1.8  
Warrants Outstanding

Warrants consisted of the following as of and for the three months ended April 30, 2013:

 

    Aggregate     Number of  
    intrinsic value     warrants  
Outstanding at January 31, 2013   $ -       2,936,000  
Granted     -       75,000  
Exercised     -       -  
Cancelled     -       -  
Outstanding at April 30, 2013   $ -       3,011,000  

 

            Weighted              
            average           Weighted  
      Warrants     remaining     Warrants     average  
Exercise Price     outstanding     contractual life     exercisable     exercise price  
$ 0.11485       1,250,000       3.25       1,250,000     $ 0.1149  
$ 0.11485       250,000       3.25       250,000     $ 0.1149  
$ 0.45000       500,000       3.25       500,000     $ 0.4500  
$ 0.50000       100,000       4.50       100,000     $ 0.5000  
$ 0.45000       735,000       4.76       735,000     $ 0.4500  
$ 0.40000       176,000       4.76       176,000     $ 0.4000  
          3,011,000       3.75       3,011,000     $ 0.2818  
Amount of Shares of Common Stock Reserved

The amount of shares of common stock reserved for these purposes is as follows at April 30, 2013: 

 

 Common stock issued and outstanding     34,843,441  
 Conversion of 10% Notes     10,883,761  
 Conversion of 8% Notes     600,000  
 Conversion of 9% Notes     2,006,283  
 Warrants outstanding     3,011,000  
 Stock options outstanding     5,832,000  
 Shares issuable under 2013 Equity Incentive Plan     3,810,333  
      60,986,818